VentureMed Group
Plymouth, Minnesota, United States · Healthcare, Health Care · 32 employees
VentureMed Group, Inc. is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral vascular disease interventions. The company's flagship technology, the FLEX Vessel Prep™ System, is an FDA 510(k)-cleared and CE Mark-approved device, that is designed to optimize vessel preparation using its prop
Funding history
- Venture - Series Unknown — $49.2M — Oct 2025
- Series C — $28.0M — Oct 2025
- Venture - Series Unknown — $7.0M — Feb 2025
- Seed — $7.0M — Nov 2024
Recent signals
- Feb 11, 2026: VentureMed Group Appoints Bruce Fiedler as Chief Financial Officer
- Oct 31, 2025: Raised $49.2M in Venture - Series Unknown
- Oct 29, 2025: Raised $28.0M in Series C
- Mar 12, 2025: VentureMed Group Expands Commercial Leadership Team to Accelerate Growth
- Feb 12, 2025: Raised $7.0M in Venture - Series Unknown
- Nov 12, 2024: Raised $7.0M in Seed
See plans & pricing → Track VentureMed Group’s funding, hiring, and signals — with verified contacts — on Fundz.